Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Gilead Sciences, Inc.
Type
Public
Traded as NASDAQ: GILD
S&P 500 Component
NASDAQ Biotechnology Component
Industry Biotechnology
Founded 1987; 28 years ago (1987)
Headquarters Foster City, California, U.S.
Key people
John C. Martin,
(President and Chief Executive Officer)
Products AmBisome, Atripla, Cayston, Emtriva, Flolan, Harvoni, Hepsera, Letairis, Lexiscan, Macugen, Ranexa, Sovaldi, Tamiflu, Truvada, Viread, Vistide
Revenue Increase US$24.474 billion (2014)
Operating income
Increase US $15.265 billion (2014)
Net income
Increase US $12.059 billion (2014)
Total assets Increase US $34.664 billion (2014)
Total equity Increase US $15.834 billion (2014)
Number of employees
7,000 (2015)
Website www.gilead.com

Gilead Sciences is an American biotechnology company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected with HIV, hepatitis B, hepatitis C, or influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with pulmonary diseases. The company has fourteen commercially available products. Headquartered and founded in Foster City, California, Gilead has operations in North America, Europe and Australia. As of the end of 2009, the company had approximately 4,000 full-time employees. The company's name and logo refer to the Balm of Gilead.

Investment goal date:
Dividends reinvested
Gilead Sciences, Inc. GILD report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-04-30
--
--
Q4 2017
2018-02-05
--
--
Q3 2017
2017-10-26
2.2700
2.0600
Q2 2017
2017-07-26
2.5600
2.3300
Q1 2017
2017-05-02
2.2300
2.0500
Q4 2016
2017-02-07
2.7000
2.3400
Q3 2016
2016-11-01
2.7500
2.4900
Q2 2016
2016-07-25
3.0800
2.5800
Q1 2016
2016-04-28
3.0300
2.5300
Q4 2015
2016-02-02
3.3200
3.1800
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BANK OF AMERICA CORP /DE/
15408527
Bank of New York Mellon Corp
30570798
BlackRock Fund Advisors
28509283
BlackRock Inc.
102969463
BlackRock Institutional Trust Company, N.A.
36939759
Capital Research Global Investors
21474531
FMR LLC
22779298
FRANKLIN RESOURCES INC
14379174
GEODE CAPITAL MANAGEMENT, LLC
14417098
Invesco Ltd.
18153295
NORTHERN TRUST CORP
16313696
PARNASSUS INVESTMENTS /CA
16726150
STATE STREET CORP
60006200
TEMASEK HOLDINGS (PRIVATE) LTD
14444216
Vanguard Group, Inc
90693263
Major Shareholders
Name Relationship
Total Shares
Holding stocks
WOLD OLSEN PER
0.0100% (93330)
GILD /
BISCHOFBERGER NORBERT W
0.1500% (2318407)
GILD /
MARTIN JOHN C
0.2000% (2996766)
GILD /
MILLIGAN JOHN F
0.0800% (1165924)
GILD / PACB /
DAVIGNON ETIENNE
0.0600% (838652)
GILD /
WILSON GAYLE E
0.0100% (122258)
GILD /
% ()